Article
De novo design of therapeutic scFvs and multi-specific engagers from sequence alone
2026-03-18
Abstract excerpt
The discovery of functional antibody therapeutics is fundamentally constrained by the astronomical complexity of the sequence landscape and the inefficiency of empirical screening. While structure-based computational design has made significant strides, its reliance on high-resolution co-complex data restricts its utility against the vast undruggable proteome and rapidly evolving pathogens. Here, we introduce IASO...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 44c340ad-2575-5b58-a53a-a6d3a639b639
- DOI
- 10.64898/2026.03.17.712263
